Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BioMaxima financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
ZŁ14.6
2024-10-29
Market Capitalization
ZŁ61.2 M
2024-10-29
Revenue
ZŁ52.9 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| PLN | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 30.8M | 30.5M | 61.6M | 78.3M | 143.9M | 46.8M | 52.9M |
| Cost of goods sold | 21.9M | 20.2M | 41.0M | 53.6M | 94.6M | 30.1M | 33.0M |
| Gross profit | 10.3M | 12.0M | 22.3M | 26.2M | 50.9M | 18.3M | 20.9M |
| Gross profit margin, % | 33.5% | 39.5% | 36.2% | 33.5% | 35.4% | 39.2% | 39.5% |
| Operating expense total | 8.9M | 9.6M | 10.8M | 10.8M | 14.1M | 15.1M | 16.2M |
| Depreciation and amortization | 1.5M | 1.7M | 1.9M | 1.6M | 2.0M | 2.5M | 3.4M |
| EBITDA | 1.5M | 2.5M | 11.5M | 15.4M | 36.9M | 3.2M | 4.6M |
| EBITDA margin, % | 4.7% | 8.1% | 18.7% | 19.6% | 25.7% | 6.9% | 8.8% |
| EBIT | 40.0K | 721.0K | 9.6M | 13.8M | 34.9M | 759.0K | 1.3M |
| EBIT margin, % | 0.1% | 2.4% | 15.5% | 17.6% | 24.3% | 1.6% | 2.4% |
| Interest income | 56.0K | 70.0K | 100.0K | 100.0K | 799.0K | 138.0K | 2.0K |
| Interest expense | 329.0K | 587.0K | 684.0K | 202.0K | 475.0K | 609.0K | 978.0K |
| Pre tax profit | (531.0K) | 182.0K | 8.7M | 13.1M | 35.9M | 187.0K | 306.0K |
| Income tax expense | (69.0K) | 168.0K | 1.4M | 2.5M | 7.0M | (399.0K) | (229.0K) |
| Net Income | (462.0K) | 14.0K | 7.3M | 10.6M | 28.9M | 586.0K | 535.0K |